Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |